• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-4651 通过靶向结合溴结构域蛋白 4 抑制非小细胞肺癌细胞的进展。

MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression.

机构信息

Department of Respiratory Medicine, Affiliated Wujiang Hospital of Nantong University, Suzhou, China; Department of Respiratory Medicine, the First Affiliated Hospital of Soochow University, Suzhou, China.

Department of Radiotherapy and Oncology, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, China.

出版信息

Cancer Lett. 2020 Apr 28;476:129-139. doi: 10.1016/j.canlet.2020.02.018. Epub 2020 Feb 17.

DOI:10.1016/j.canlet.2020.02.018
PMID:32081805
Abstract

Bromodomain-containing protein 4 (BRD4) overexpression in non-small cell lung cancer (NSCLC) promotes cancer progression. Here, we show that miR-4651 selectively targets and negatively regulates BRD4 in A549 and primary human NSCLC cells. RNA pull-down experiments confirmed that miR-4651 directly binds to BRD4 mRNA. Further, ectopic overexpression of miR-4651 in A549 cells and primary NSCLC cells decreased BRD4 3'-UTR luciferase reporter activity and its expression, whereas miR-4651 inhibition elevated both. Functional studies demonstrated that NSCLC cell growth, proliferation, and migration were suppressed with ectopic miR-4651 overexpression but enhanced with miR-4651 inhibition. BRD4 re-expression using a 3'-UTR mutant BRD4 reversed A549 cell inhibition induced by miR-4651 overexpression. Further, miR-4651 overexpression or inhibition failed to alter the functions of BRD4-KO A549 cells. In vivo, miR-4651-overexpressing A549 xenografts grew slowly than control A549 xenografts in severe combined immunodeficient mice. Finally, miR-4651 was downregulated in human NSCLC tissues, correlating with BRD4 elevation. Together, miR-4651 targets BRD4 to inhibit NSCLC cell growth in vitro and in vivo.

摘要

溴结构域蛋白 4(BRD4)在非小细胞肺癌(NSCLC)中的过表达促进了癌症的进展。在这里,我们表明 miR-4651 选择性地靶向和负调控 A549 和原发性人非小细胞肺癌细胞中的 BRD4。RNA 下拉实验证实 miR-4651 可直接结合 BRD4 mRNA。此外,miR-4651 在 A549 细胞和原发性 NSCLC 细胞中的过表达降低了 BRD4 3'-UTR 荧光素酶报告基因活性及其表达,而 miR-4651 抑制则升高了两者。功能研究表明,过表达 miR-4651 可抑制 NSCLC 细胞的生长、增殖和迁移,但抑制 miR-4651 则增强了这些作用。使用 3'-UTR 突变型 BRD4 进行 BRD4 再表达可逆转 miR-4651 过表达诱导的 A549 细胞抑制。此外,miR-4651 过表达或抑制均未能改变 BRD4-KO A549 细胞的功能。体内,miR-4651 过表达的 A549 异种移植在严重联合免疫缺陷小鼠中比对照 A549 异种移植生长缓慢。最后,miR-4651 在人非小细胞肺癌组织中下调,与 BRD4 升高相关。总之,miR-4651 通过靶向 BRD4 抑制 NSCLC 细胞在体外和体内的生长。

相似文献

1
MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression.miRNA-4651 通过靶向结合溴结构域蛋白 4 抑制非小细胞肺癌细胞的进展。
Cancer Lett. 2020 Apr 28;476:129-139. doi: 10.1016/j.canlet.2020.02.018. Epub 2020 Feb 17.
2
Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.环状 RNA circ_0074027 提示 NSCLC 患者预后不良,并通过 miR-185-3p 介导的 BRD4/MADD 激活调节细胞增殖、凋亡和侵袭。
J Cell Biochem. 2020 Mar;121(3):2632-2642. doi: 10.1002/jcb.29484. Epub 2019 Nov 3.
3
microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.miRNA-100 通过靶向 HOXA1 调控上皮-间充质转化和 Wnt/β-catenin 通路发挥抑癌作用在非小细胞肺癌中
Thorac Cancer. 2020 Jun;11(6):1679-1688. doi: 10.1111/1759-7714.13459. Epub 2020 May 4.
4
LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.长链非编码 RNA SNHG16 通过海绵吸附 miR-520a-3p 调控 EphA2 表达促进非小细胞肺癌发展。
Thorac Cancer. 2020 Mar;11(3):603-611. doi: 10.1111/1759-7714.13304. Epub 2020 Jan 17.
5
MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition.微小RNA-183通过抑制叉头框蛋白O1促进非小细胞肺癌细胞生长。
Tumour Biol. 2015 Sep;36(10):8121-6. doi: 10.1007/s13277-015-3550-8. Epub 2015 May 17.
6
CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145.环状 RNA BIRC6 通过海绵吸附 microRNA-145 促进非小细胞肺癌细胞的进展。
Cell Oncol (Dordr). 2020 Jun;43(3):477-488. doi: 10.1007/s13402-020-00503-x. Epub 2020 Apr 15.
7
MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.微小 RNA-101 通过直接靶向增强子结合锌指蛋白 2 在非小细胞肺癌中发挥肿瘤抑制功能。
J Thorac Oncol. 2011 Apr;6(4):671-8. doi: 10.1097/JTO.0b013e318208eb35.
8
Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression.靶向 BRD4 蛋白通过下调 eIF4E 表达抑制 NSCLC 的生长。
Cancer Biol Ther. 2018 May 4;19(5):407-415. doi: 10.1080/15384047.2018.1423923. Epub 2018 Feb 6.
9
miR-874 directly targets AQP3 to inhibit cell proliferation, mobility and EMT in non-small cell lung cancer.miR-874 直接靶向 AQP3 抑制非小细胞肺癌细胞增殖、迁移和 EMT。
Thorac Cancer. 2020 Jun;11(6):1550-1558. doi: 10.1111/1759-7714.13428. Epub 2020 Apr 16.
10
MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.微小 RNA-100 是非小细胞肺癌的潜在分子标志物,通过靶向 Polo 样激酶 1 发挥肿瘤抑制作用。
BMC Cancer. 2012 Nov 14;12:519. doi: 10.1186/1471-2407-12-519.

引用本文的文献

1
Performance of a Logistic Regression Model Using Paired miRNAs to Stratify Abnormal Mammograms for Benign Breast Lesions.使用配对的微小RNA构建逻辑回归模型以对乳腺钼靶异常进行分层诊断良性乳腺病变
Cancer Med. 2025 Apr;14(8):e70767. doi: 10.1002/cam4.70767.
2
The Circular RNA Circ_0043947 Promoted Gastric Cancer Progression by Sponging miR-384 to Regulate CREB1 Expression.环状 RNA Circ_0043947 通过海绵吸附 miR-384 调控 CREB1 表达促进胃癌进展。
Gut Liver. 2024 Nov 15;18(6):977-991. doi: 10.5009/gnl230173. Epub 2024 Apr 19.
3
Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
鉴定基质重塑相关 5 作为胰腺癌的潜在分子肿瘤靶点。
Cell Death Dis. 2023 Feb 24;14(2):157. doi: 10.1038/s41419-023-05684-5.
4
A novel prognostic model based on three clinic-related miRNAs for prostate cancer.一种基于三种临床相关微小RNA的前列腺癌新型预后模型。
Front Surg. 2022 Jul 25;9:872953. doi: 10.3389/fsurg.2022.872953. eCollection 2022.
5
Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.新型双重抑制剂 SKI-349 通过靶向鞘氨醇激酶 1/2 抑制非小细胞肺癌细胞生长。
Cell Death Dis. 2022 Jul 12;13(7):602. doi: 10.1038/s41419-022-05049-4.
6
The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth.鞘氨醇激酶抑制剂 SKI-V 抑制宫颈癌细胞生长。
Int J Biol Sci. 2022 Apr 18;18(7):2994-3005. doi: 10.7150/ijbs.71381. eCollection 2022.
7
Molecular Dynamic Simulations of Bromodomain and Extra-Terminal Protein 4 Bonded to Potent Inhibitors.溴结构域和额外末端蛋白 4 与有效抑制剂结合的分子动力学模拟。
Molecules. 2021 Dec 26;27(1):118. doi: 10.3390/molecules27010118.
8
RYR2 mutation in non-small cell lung cancer prolongs survival via down-regulation of DKK1 and up-regulation of GS1-115G20.1: A weighted gene Co-expression network analysis and risk prognostic models.RYR2 突变通过下调 DKK1 和上调 GS1-115G20.1 延长非小细胞肺癌的生存期:一项基于加权基因共表达网络分析和风险预后模型的研究。
IET Syst Biol. 2022 Apr;16(2):43-58. doi: 10.1049/syb2.12038. Epub 2021 Dec 7.
9
Circ_0000376 downregulation inhibits the progression of non-small cell lung cancer by mediating the miR-488-3p/BRD4 axis and the PI3K/PKB signaling pathway.Circ_0000376下调通过介导miR-488-3p/BRD4轴和PI3K/PKB信号通路抑制非小细胞肺癌进展。
Histol Histopathol. 2021 Dec;36(12):1309-1324. doi: 10.14670/HH-18-390. Epub 2021 Nov 3.
10
SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth.SREBP1 位点 1 蛋白酶抑制剂 PF-429242 抑制肾细胞癌细胞生长。
Cell Death Dis. 2021 Jul 20;12(8):717. doi: 10.1038/s41419-021-03999-9.